Sequent Scientific Limited (BOM:512529)
India · Delayed Price · Currency is INR 172.15
-3.70 (-2.10%)
At close: Jul 31, 2025
Sequent Scientific Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| 15,514 | 13,697 | 14,209 | 14,128 | 13,616 | Upgrade | |
Revenue Growth (YoY) | 13.26% | -3.60% | 0.57% | 3.76% | 15.47% | Upgrade |
Cost of Revenue | 8,375 | 7,853 | 8,581 | 8,149 | 7,165 | Upgrade |
Gross Profit | 7,139 | 5,845 | 5,628 | 5,979 | 6,451 | Upgrade |
Selling, General & Admin | 2,898 | 2,548 | 2,618 | 2,334 | 1,883 | Upgrade |
Other Operating Expenses | 2,569 | 2,448 | 2,605 | 2,547 | 2,344 | Upgrade |
Operating Expenses | 6,131 | 5,612 | 5,781 | 5,400 | 4,763 | Upgrade |
Operating Income | 1,007 | 232.73 | -153.46 | 579.62 | 1,688 | Upgrade |
Interest Expense | -559.56 | -464.23 | -297.19 | -135.09 | -192.54 | Upgrade |
Interest & Investment Income | 27.24 | 6.7 | 12.1 | 4.07 | 16.21 | Upgrade |
Currency Exchange Gain (Loss) | -80.49 | -153.49 | -114.46 | 63.03 | -42.16 | Upgrade |
Other Non Operating Income (Expenses) | 9.99 | 29.97 | -27.11 | 15.52 | -16.64 | Upgrade |
EBT Excluding Unusual Items | 404.58 | -348.32 | -580.12 | 527.15 | 1,452 | Upgrade |
Merger & Restructuring Charges | -16.81 | -228.14 | -421.76 | - | -38.26 | Upgrade |
Impairment of Goodwill | - | - | -204.09 | - | - | Upgrade |
Gain (Loss) on Sale of Investments | 1.49 | 0.17 | 0.51 | 3.18 | 25.79 | Upgrade |
Gain (Loss) on Sale of Assets | 60.18 | 55.42 | 20.42 | -0.69 | 6.98 | Upgrade |
Asset Writedown | -2.75 | -1.64 | -1.61 | -0.34 | -30.69 | Upgrade |
Other Unusual Items | -10.68 | -104.62 | -189.93 | - | -49.97 | Upgrade |
Pretax Income | 443.06 | -546.46 | -1,377 | 529.3 | 1,366 | Upgrade |
Income Tax Expense | 120.47 | -250.33 | -156.81 | 81.66 | 321.77 | Upgrade |
Earnings From Continuing Operations | 322.59 | -296.13 | -1,220 | 447.64 | 1,045 | Upgrade |
Net Income to Company | 322.59 | -296.13 | -1,220 | 447.64 | 1,045 | Upgrade |
Minority Interest in Earnings | -103.81 | -62.56 | 8.18 | -38.09 | -90.1 | Upgrade |
Net Income | 218.78 | -358.69 | -1,212 | 409.55 | 954.42 | Upgrade |
Net Income to Common | 218.78 | -358.69 | -1,212 | 409.55 | 954.42 | Upgrade |
Net Income Growth | - | - | - | -57.09% | 36.53% | Upgrade |
Shares Outstanding (Basic) | 249 | 249 | 248 | 247 | 247 | Upgrade |
Shares Outstanding (Diluted) | 256 | 250 | 248 | 251 | 248 | Upgrade |
Shares Change (YoY) | 2.55% | 0.57% | -0.90% | 1.16% | 1.04% | Upgrade |
EPS (Basic) | 0.88 | -1.44 | -4.88 | 1.66 | 3.87 | Upgrade |
EPS (Diluted) | 0.85 | -1.44 | -4.88 | 1.63 | 3.85 | Upgrade |
EPS Growth | - | - | - | -57.66% | 35.09% | Upgrade |
Free Cash Flow | 442.75 | -2.12 | -693.71 | -18.69 | 619.24 | Upgrade |
Free Cash Flow Per Share | 1.73 | -0.01 | -2.79 | -0.07 | 2.50 | Upgrade |
Dividend Per Share | - | - | - | - | 0.500 | Upgrade |
Gross Margin | 46.02% | 42.67% | 39.61% | 42.32% | 47.38% | Upgrade |
Operating Margin | 6.49% | 1.70% | -1.08% | 4.10% | 12.39% | Upgrade |
Profit Margin | 1.41% | -2.62% | -8.53% | 2.90% | 7.01% | Upgrade |
Free Cash Flow Margin | 2.85% | -0.01% | -4.88% | -0.13% | 4.55% | Upgrade |
EBITDA | 1,582 | 767.82 | 311.55 | 983.02 | 2,092 | Upgrade |
EBITDA Margin | 10.20% | 5.61% | 2.19% | 6.96% | 15.36% | Upgrade |
D&A For EBITDA | 574.85 | 535.09 | 465.01 | 403.4 | 404.26 | Upgrade |
EBIT | 1,007 | 232.73 | -153.46 | 579.62 | 1,688 | Upgrade |
EBIT Margin | 6.49% | 1.70% | -1.08% | 4.10% | 12.39% | Upgrade |
Effective Tax Rate | 27.19% | - | - | 15.43% | 23.55% | Upgrade |
Revenue as Reported | 15,661 | 13,807 | 14,273 | 14,237 | 13,700 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.